Closing Bell: Fennec Pharmaceuticals Inc down on Tuesday (FRX)

In today's trading, Fennec Pharmaceuticals Inc shares closed at $7.95 after opening the day at $7.95. Intraday prices ranged from $7.95 to $7.95.

The price decreased -0.38% from the previous day's close of $7.98.

During the day across North America, the TSX Composite closed -2.18% at 22227.63, the S&P 500 closed -3.00% at 5186.33, the Dow Jones Industrial Average closed -2.60% at 38703.27 and the Nasdaq Composite closed -3.43% at 16200.08.

Fennec Pharmaceuticals Inc has listed on the Toronto Stock Exchange (TSX) under the ticker FRX.

A total of 114 shares was traded during the last trading day, with total trades of 3. On average, Fennec Pharmaceuticals Inc has traded 369 shares in the last five days and 1,687 year-to-date.

The TSX market on the whole today saw 3,772 price advancers against 1,443 declines and 86 unchanged.

During the prior 52 weeks, FRX.TO has traded as high as $15.43 (December 28,2023) and low as $7.80 (July 05,2024). Moreover, the shares have shrunken -25.21 percent in the last 52 weeks, while in 2024, they have shrunken -47.56%.

Following today's trading, Fennec Pharmaceuticals Inc has a market capitalization of $218.03 million on a float of 27,322 shares outstanding. Its annual EPS is $0.04.

Fennec Pharmaceuticals Inc is a TSX Biotechnology company headquartered in Research Triangle Park, USA.

Currently, Fennec Pharmaceuticals Inc has an average recommendation of "Strong Buy" based on 6.00 analysts according to Zacks. Currently, there are 6 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..